← Back to Search

Multisensory Training for Hemianopia

N/A
Waitlist Available
Led By Benjamin A Rowland, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >= 18 years old
Be older than 18 years old
Must not have
Current major medical problems that might independently affect cognition, vision, or interfere with ability to attend study visits. This includes pathology of the retina or optic nerve explanatory of blindness
Unable or unwilling to attend scheduled testing and training sessions, including the 12 month follow up
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 64
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to restore vision in stroke patients using a multi-sensory training technique and evaluate its effects on the brain.

Who is the study for?
Adults over 18 with stable homonymous hemianopia for at least 6 months, or new cases less than a month old. Participants must speak English, be cognitively normal, have reliable transportation, and be MRI compatible. Exclusions include current major medical issues affecting cognition or vision, substance abuse, other neurological disorders like dementia or Parkinson's disease.
What is being tested?
The trial is testing multisensory training to improve vision in patients with blindness caused by stroke. It compares the effectiveness of this technique on those with long-standing blindness versus those recently affected.
What are the potential side effects?
Since this study involves non-invasive training techniques rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have major health issues affecting my thinking, sight, or ability to attend study visits.
Select...
I can attend all required tests, training, and follow-up sessions.
Select...
I do not have a major neurological disorder that could affect my ability to follow instructions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 64
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 64 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical Ophthalmological Test Scores
Functional magnetic resonance imaging (fMRI) scans
Quality of Life (QoL) Assessment
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Standard Intervention: Multisensory TrainingExperimental Treatment1 Intervention
Patients with stable hemianopia (\>6 months) are given multisensory training
Group II: Early Intervention: Multisensory TrainingExperimental Treatment1 Intervention
Patients with early hemianopia (\<1 months) are given multisensory training
Group III: Standard Intervention: Unisensory TrainingActive Control2 Interventions
Patients with stable hemianopia (\>6 months) are given auditory training and crossover to multisensory training
Group IV: Early Intervention: Unisensory TrainingActive Control2 Interventions
Patients with early hemianopia (\<1 months) are given auditory training and crossover to multisensory training

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,361 Previous Clinical Trials
1,039,937 Total Patients Enrolled
1 Trials studying Homonymous Hemianopia
6 Patients Enrolled for Homonymous Hemianopia
Benjamin A Rowland, PhDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Multisensory Training Clinical Trial Eligibility Overview. Trial Name: NCT05894434 — N/A
Homonymous Hemianopia Research Study Groups: Standard Intervention: Multisensory Training, Standard Intervention: Unisensory Training, Early Intervention: Multisensory Training, Early Intervention: Unisensory Training
Homonymous Hemianopia Clinical Trial 2023: Multisensory Training Highlights & Side Effects. Trial Name: NCT05894434 — N/A
Multisensory Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05894434 — N/A
~48 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top